Discovery of Human-Similar Gene Fusions in Canine Cancers

Canine cancers represent a tremendous natural resource due to their incidence and striking similarities to human cancers, sharing similar clinical and pathologic features as well as oncogenic events, including identical somatic mutations. Considering the importance of gene fusions as driver alterati...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 77; no. 21; pp. 5721 - 5727
Main Authors Ulvé, Ronan, Rault, Mélanie, Bahin, Mathieu, Lagoutte, Laetitia, Abadie, Jérôme, De Brito, Clotilde, Coindre, Jean-Michel, Botherel, Nadine, Rousseau, Audrey, Wucher, Valentin, Cadieu, Edouard, Thieblemont, Catherine, Hitte, Christophe, Cornevin, Laurence, Cabillic, Florian, Bachelot, Laura, Gilot, David, Hennuy, Benoit, Guillaudeux, Thierry, Le Goff, Arnaud, Derrien, Thomas, Hédan, Benoît, André, Catherine
Format Journal Article
LanguageEnglish
Published United States American Association for Cancer Research, Inc 01.11.2017
American Association for Cancer Research
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Canine cancers represent a tremendous natural resource due to their incidence and striking similarities to human cancers, sharing similar clinical and pathologic features as well as oncogenic events, including identical somatic mutations. Considering the importance of gene fusions as driver alterations, we explored their relevance in canine cancers. We focused on three distinct human-comparable canine cancers representing different tissues and embryonic origins. Through RNA-Seq, we discovered similar gene fusions as those found in their human counterparts: - in B-cell lymphoma, - in glioma, and - in dermatofibrosarcoma protuberans-like. We showed not only similar partner genes but also identical breakpoints leading to oncogene overexpression. This study demonstrates similar gene fusion partners and mechanisms in human-dog corresponding tumors and allows for selection of targeted therapies in preclinical and clinical trials with pet dogs prior to human trials, within the framework of personalized medicine. .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0008-5472
1538-7445
DOI:10.1158/0008-5472.CAN-16-2691